Fresenius SE KGaA (XTER:FRE) Cyclically Adjusted Revenue per Share: €64.17 (As of Mar. 2026)


XTER:FRE Fresenius SE & Co KGaA XTER:FRE
66 GF Score
Price €41.03
GF Value €36.57
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is Fresenius SE KGaA Cyclically Adjusted Revenue per Share?

Fresenius SE KGaA XTER:FRE +2.65% 66 Cyclically Adjusted Revenue per Share is €64.17 as of Mar. 2026. GuruFocus rates XTER:FRE with a GF Score™ of 66/100 and a GF Value™ of €36.57 (Modestly Overvalued). The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Fresenius SE KGaA's adjusted revenue per share for the three months ended in Mar. 2026 was €10.330. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is €64.17 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Fresenius SE KGaA's average Cyclically Adjusted Revenue Growth Rate was -1.20% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 0.20% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 4.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Fresenius SE KGaA was 8.60% per year. The lowest was 0.20% per year. And the median was 6.85% per year.

As of today (2026-07-02), Fresenius SE KGaA's current stock price is €41.03. Fresenius SE KGaA's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was €64.17. Fresenius SE KGaA's Cyclically Adjusted PS Ratio of today is 0.64.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Fresenius SE KGaA was 1.91. The lowest was 0.32. And the median was 0.72.


Fresenius SE KGaA  (XTER:FRE) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Fresenius SE KGaA's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=41.03/64.17
=0.64

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Fresenius SE KGaA was 1.91. The lowest was 0.32. And the median was 0.72.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Fresenius SE KGaA Cyclically Adjusted Revenue per Share Related Terms


Fresenius SE KGaA Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Fresenius SE KGaA's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fresenius SE KGaA Cyclically Adjusted Revenue per Share Chart

Fresenius SE KGaA Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 57.60 63.41 64.86 65.08 63.87

Fresenius SE KGaA Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 64.95 64.65 64.44 63.87 64.17

XTER:FRE vs HCA, THC, DVA: Cyclically Adjusted Revenue per Share Comparison

For the Medical Care Facilities subindustry, Fresenius SE KGaA's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fresenius SE KGaA Cyclically Adjusted PS Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Fresenius SE KGaA's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Fresenius SE KGaA's Cyclically Adjusted PS Ratio falls into.


XTER:FRE
66GF Score
Fresenius SE & Co KGaA XTER:FRE
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Fresenius SE KGaA Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Fresenius SE KGaA's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=10.33/131.2583*131.2583
=10.330

Current CPI (Mar. 2026) = 131.2583.

Fresenius SE KGaA Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 13.124 100.717 17.104
201609 13.402 101.017 17.414
201612 14.180 101.217 18.389
201703 14.962 101.417 19.364
201706 15.329 102.117 19.703
201709 14.849 102.717 18.975
201712 15.567 102.617 19.912
201803 14.542 102.917 18.547
201806 15.014 104.017 18.946
201809 14.637 104.718 18.347
201812 15.825 104.217 19.931
201903 15.216 104.217 19.164
201906 15.782 105.718 19.595
201909 15.704 106.018 19.443
201912 16.663 105.818 20.669
202003 16.359 105.718 20.311
202006 16.031 106.618 19.736
202009 15.968 105.818 19.807
202012 16.656 105.518 20.719
202103 16.081 107.518 19.632
202106 16.577 108.486 20.057
202109 16.706 109.435 20.038
202112 17.845 110.384 21.220
202203 17.404 113.968 20.044
202206 17.787 115.760 20.168
202209 9.564 118.818 10.565
202212 10.067 119.345 11.072
202303 9.847 122.402 10.559
202306 9.312 123.140 9.926
202309 9.209 124.195 9.733
202312 9.545 123.773 10.122
202403 9.499 125.038 9.972
202406 9.626 125.882 10.037
202409 9.456 126.198 9.835
202412 10.385 127.041 10.730
202503 10.131 127.779 10.407
202506 9.809 128.412 10.026
202509 9.886 129.255 10.039
202512 10.930 129.361 11.090
202603 10.330 131.258 10.330

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of €64.17 mean?
Fresenius SE KGaA (XTER:FRE) has a Cyclically Adjusted Revenue per Share of €64.17 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Fresenius SE KGaA and its competitors.
Is Fresenius SE KGaA's Cyclically Adjusted Revenue per Share too high?
Fresenius SE KGaA's current Cyclically Adjusted Revenue per Share is €64.17. Overall, Fresenius SE KGaA has a GF Score™ of 66/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Fresenius SE KGaA's Cyclically Adjusted Revenue per Share compare to HCA and THC?
Fresenius SE KGaA's Cyclically Adjusted Revenue per Share of €64.17 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Healthcare Providers & Services company?
A good Cyclically Adjusted Revenue per Share depends on the Healthcare Providers & Services industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Fresenius SE KGaA and its competitors. Fresenius SE KGaA's current Cyclically Adjusted Revenue per Share is €64.17. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fresenius SE KGaA stock overvalued right now?
Based on GuruFocus' analysis, Fresenius SE KGaA (XTER:FRE) is currently considered Modestly Overvalued. The stock's GF Value™ is €36.57, compared to a current price of €41.03 — trading 12.2% above its estimated fair value. The current Cyclically Adjusted Revenue per Share is €64.17. Fresenius SE KGaA's overall GF Score™ is 66/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Fresenius SE KGaA (XTER:FRE), the current Cyclically Adjusted Revenue per Share is €64.17 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Fresenius SE KGaA (XTER:FRE) Overvalued in 2026?

Based on GuruFocus' analysis, Fresenius SE KGaA stock appears to be overvalued. The current stock price of €41.03 is trading 12.2% above its estimated GF Value™ of €36.57. GuruFocus considers Fresenius SE KGaA to be Modestly Overvalued.

Key valuation signals for XTER:FRE:

  • Cyclically Adjusted Revenue per Share: €64.17
  • GF Value™: €36.57 vs. price of €41.03 (12.2% above fair value)
  • GF Score™: 66/100 with 5 warning signs

No single metric tells the full story. See the XTER:FRE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Fresenius SE KGaA Business Description

Address Else-Kroener-Strasse 1, Bad Homburg, HE, DEU, 61352
Fresenius is a healthcare holding company based in Germany. The company owns a minority stake in dialysis service provider and equipment manufacturer Fresenius Medical Care. The Kabi segment manufactures intravenous drugs, nutrition products, infusion and transfusion therapies, and related pumps. The Helios segment operates private hospitals primarily in Germany and Spain.
66GF Score

Get the complete analysis for XTER:FRE

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€41.03
Price
€36.57
GF Value